BNP Paribas Acquires 2,699 Shares of Intuitive Surgical, Inc. $ISRG

BNP Paribas increased its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 8.8% during the fourth quarter, HoldingsChannel.com reports. The fund owned 33,423 shares of the medical equipment provider’s stock after buying an additional 2,699 shares during the quarter. BNP Paribas’ holdings in Intuitive Surgical were worth $18,930,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also bought and sold shares of the business. Lingotto Investment Management LLP grew its position in Intuitive Surgical by 41.1% during the fourth quarter. Lingotto Investment Management LLP now owns 107,756 shares of the medical equipment provider’s stock worth $61,029,000 after buying an additional 31,399 shares in the last quarter. Arcadia Investment Management Corp MI grew its position in Intuitive Surgical by 56.7% during the fourth quarter. Arcadia Investment Management Corp MI now owns 3,448 shares of the medical equipment provider’s stock worth $1,953,000 after buying an additional 1,248 shares in the last quarter. New Mexico Educational Retirement Board grew its position in Intuitive Surgical by 4.3% during the fourth quarter. New Mexico Educational Retirement Board now owns 16,842 shares of the medical equipment provider’s stock worth $9,539,000 after buying an additional 700 shares in the last quarter. SCS Capital Management LLC grew its position in Intuitive Surgical by 4.9% during the fourth quarter. SCS Capital Management LLC now owns 936 shares of the medical equipment provider’s stock worth $530,000 after buying an additional 44 shares in the last quarter. Finally, Peapack Gladstone Financial Corp grew its position in Intuitive Surgical by 13.0% during the fourth quarter. Peapack Gladstone Financial Corp now owns 18,584 shares of the medical equipment provider’s stock worth $10,525,000 after buying an additional 2,136 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors.

Intuitive Surgical Stock Performance

ISRG stock opened at $412.26 on Tuesday. Intuitive Surgical, Inc. has a fifty-two week low of $411.83 and a fifty-two week high of $603.88. The business’s 50 day moving average price is $452.19 and its two-hundred day moving average price is $504.81. The company has a market capitalization of $146.01 billion, a price-to-earnings ratio of 49.97, a price-to-earnings-growth ratio of 3.39 and a beta of 1.46.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.08 by $0.42. The business had revenue of $2.77 billion for the quarter, compared to analysts’ expectations of $2.62 billion. Intuitive Surgical had a return on equity of 15.98% and a net margin of 28.15%.The firm’s quarterly revenue was up 23.0% on a year-over-year basis. During the same period in the prior year, the firm posted $1.81 EPS. Sell-side analysts forecast that Intuitive Surgical, Inc. will post 8.57 earnings per share for the current year.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, EVP Gary Loeb sold 400 shares of the stock in a transaction on Monday, May 11th. The stock was sold at an average price of $446.95, for a total value of $178,780.00. Following the completion of the sale, the executive vice president owned 6,120 shares in the company, valued at approximately $2,735,334. This represents a 6.13% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Myriam Curet sold 105 shares of the stock in a transaction on Tuesday, March 10th. The stock was sold at an average price of $493.95, for a total value of $51,864.75. The disclosure for this sale is available in the SEC filing. Insiders sold 4,833 shares of company stock valued at $2,357,582 over the last 90 days. 0.60% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

ISRG has been the subject of several research analyst reports. Evercore dropped their price target on Intuitive Surgical from $550.00 to $480.00 and set a “neutral” rating for the company in a research note on Monday, April 6th. Argus dropped their price target on Intuitive Surgical from $630.00 to $560.00 and set a “buy” rating for the company in a research note on Wednesday, February 4th. Raymond James Financial lowered their target price on Intuitive Surgical from $615.00 to $577.00 and set an “outperform” rating for the company in a research note on Wednesday, April 22nd. HSBC lowered their target price on Intuitive Surgical from $653.00 to $604.00 and set a “buy” rating for the company in a research note on Wednesday, April 22nd. Finally, Bank of America lowered their target price on Intuitive Surgical from $650.00 to $520.00 and set a “buy” rating for the company in a research note on Monday, May 18th. Nineteen research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $576.71.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.